Gutman Diabetes Institute



In January 2001, Einstein Healthcare Network established the Gutman Diabetes Institute to provide comprehensive diabetes services. Its mission is to enhance the quality of life for those with diabetes and those at risk for developing the disease.
 

With 20 years of diabetes education experience, Nadine Uplinger, MS, RD, CDE, BC-ADM serves as Director, Gutman Diabetes Institute. She earned a master's of science degree in health education and another in healthcare administration and a bachelor's of science degree in nutrition services management. She is a member of the American Dietetic Association and of the American Association of Diabetes Educators where she has served on the Board of Directors and is a former Vice President.


Uplinger and her staff of certified diabetes educators consult approximately 100 to 150 people with diabetes per month. They see people with diabetes when they are hospitalized as inpatients and also offer Diabetes Self-Management Education (DSME) classes for outpatients. The DSME classes empower people living with diabetes to self manage their disease. Additionally, they have a Diabetes Self-Management Support group that meets monthly at St. Luke's Episcopal Church in Germantown.

 Diabetes

No one knows for sure what causes diabetes, but we do know that the number of Americans diagnosed with the disease is at a record high. According to the American Diabetes Association, approximately 17 million people in the United States have diabetes. While an estimated 11.1 million have been diagnosed, 5.9 million people are unaware that they have the disease.

If you are among the millions of Americans with diabetes, you know that the key to successfully managing the disease is education. Knowing what to eat, how to control blood sugar and cholesterol and which medications to take are all important parts of managing diabetes. Certified diabetes educators at Albert Einstein Medical Center’s Gutman Diabetes Institute can help you answer these questions and keep your diabetes under control.

Visit our Diabetes Center for more information

 Diabetes Foot Care Program

Diabetes and vascular disease often take a terrible toll on our feet, and are a leading cause of hospitalization in the United States. An estimated 15 to 25 percent of all people with diabetes will develop serious foot problems such as infection, ulceration, gangrene or fractures. If untreated or undertreated, foot conditions can result in amputation of a toe, foot or leg. But active management by specialists trained in treating foot-related complications of diabetic and vascular disease can greatly improve outcomes.

That's why Albert Einstein Medical Center and MossRehab offer the Diabetes Foot Care Program. The program offers a once-a-week clinic, a complete range of therapies and self-care education. A multidisciplinary team of medical professionals works with primary care physicians to ensure their patients obtain the frequent follow-up, education and treatment they need to avoid amputation.

Who We Can Help
Appropriate patients for evaluation and treatment are those with foot problems related to diabetes or vascular disease. Commonly treated foot conditions include, but are not limited to, infections, slow-healing wounds and ulcers resulting from corns, blisters, vascular problems and foot and ankle trauma injuries.

How the Program Works
During the clinic session, appointments are reserved for patients with diabetic and vascular foot conditions. Our services include thorough foot inspection and evaluation, wound care and cleaning (debridement), casting and physical therapy.

Surgical services through Einstein Center for Orthopedic Sciences are also available for patients with severe problems that cannot be treated conservatively. In addition, patients needing nutritional screening and education may be referred to Einstein's Gutman Diabetes Institute.

Access to Specialists
The team includes an orthopedic surgeon and a physical therapist from MossRehab. Through the program, patients can access specialists in vascular surgery, endocrinology, nutrition, internal medicine, prosthetics and orthotics, as well as certified diabetes educators from Einstein’s Gutman Diabetes Institute.

Contact Us
Talk to your physician about writing a referral to see our medical experts at the Diabetes Foot Care Program. For more information or to refer a patient, call 1-800-EINSTEIN.

 Diabetic Kidney Disease  

Diabetes is the single leading cause of kidney failure in the United States. Diabetes is a disease that affects the body’s ability to produce or respond to insulin, a hormone that allows blood glucose (blood sugar) to enter the cells of the body and be used for energy. Nephropathy, also called diabetic kidney disease, is a condition that affects one-third or more of people who have had Type 1 (juvenile) diabetes for at least 20 years. About 10 to 40 percent of people with Type 2 (adult onset) diabetes also have kidney disease.

In the United States diabetes is more common among certain ethnic groups, including: African-Americans, Hispanics, Pacific Islanders and Native Americans. The disease is extremely prevalent in the African-American community. Approximately 13 percent of all African-Americans have diabetes and one-third of this group are unaware that they have the disease. African-Americans suffer from kidney failure about four times more often than other ethnic groups.

Treatment for diabetic kidney disease focuses on slowing the progression to kidney failure. Controlling high blood pressure and blood sugar levels, participating in a doctor-supervised exercise and weight loss program and eating a special diet can help.

When kidney failure develops, the kidneys lose their ability to remove waste products from the body. The first signs of nephropathy are small amounts of protein in the urine and elevated levels of creatinine (a waste product) in the blood. Unfortunately, most people do not experience symptoms until their kidneys have lost much of their ability to function.

When kidneys function at only five to ten percent of their capacity, they can no longer process most of the waste in the body and cannot sustain a person’s life. This condition is called end-stage renal disease. Treatment options include either kidney dialysis or transplantation. In most cases, renal transplantation is often preferred for a better quality of life.

Are you at Risk for Diabetes?

Diabetes is a major risk factor for kidney disease. There are 18.2 million Americans with diabetes – and nearly one-third of them (5.2 million people) do not know it. Click here to take the American Diabetes Association’s test to find out if you are at risk for developing diabetes. African-Americans, Latinos, Native Americans, Asian Americans and Pacific Islanders are at higher risk for developing diabetes.

 News 

Einstein's Gutman Diabetes Institute Awarded Research Grant 


Philadelphia, PA, May 15, 2008 — The Gutman Diabetes Institute at Albert Einstein Healthcare Network has been awarded a one—year, $15,000 research grant to determine the impact of a ten—month self—management support group on the health status of people with diabetes. The grant is part of an Einstein—funded effort to promote community—focused research pertaining to diabetes prevention and promotion of quality of life for those living with diabetes   The principal investigator of the study is Nadine Uplinger, MS, RD, CDE, Director of the Gutman Diabetes Institute.  The co—principal investigator is Tina Harralson, PhD, Senior Scientist with Einstein's Center for Urban Health Policy and Research.  

The study will compare one group of participants who attend Diabetes Self Management Education classes at St. Luke's Episcopal Church in Germantown along with ten months of Diabetes Self—Management Support group meetings, to a control group of participants who attend the Diabetes Self Management Education classes but not the support group meetings. The St. Luke's group will consist of church members as well as Germantown residents.  The control group will attend classes at Einstein's Gutman Diabetes Institute located at the medical center, but will not have the benefit of support group meetings.

At the end of the ten months, outcomes between the two groups will be compared, including abdominal obesity, weight, body/mass index, and psychosocial measures such as how well participants cope with living with the disease. 

Another goal is for the information gained from the study to be used to develop a diabetes support group manual geared for the African American community.  

The support group, led by a certified diabetes educator, will meet every other week and will give participants an opportunity to discuss barriers to managing their diabetes, problem solving strategies, food preparation techniques, and more.  Each participant will choose two behavior goals that will assist them in achieving improved diabetes management. Participants will keep a weekly food/physical activity diary which will be reviewed, and recommendations will be made to help participants meet their goals. 

‘We recognize the importance of providing ongoing support for people living with diabetes, and we are very excited that Einstein Medical Center intends to partner with  St.Luke's to establish a diabetes support group for members of the community,’ says Nadine Uplinger.

The importance of Diabetes Self—Management Education has been well documented in the medical literature.  This education consists of teaching people how to manage their diet to improve weight and glucose control, incorporate physical activity into their life, perform blood glucose monitoring, manage medications, manage stress and reduce complications by appropriate foot and skin care. 

Current approaches to Diabetes Self—Management Education focus on short—term programs with little or no follow—up support. While this is an effective way to provide basic information to people living with diabetes, it may fall short in helping people manage this chronic disease over their lifetime.  Ongoing support is necessary for patients to sustain the improvements gained from the education they receive.  The aim of the study is to confirm or dispute this premise.

Einstein Healthcare Network
Office of Development
Braemer Building, Ground Floor
5501 Old York Road Philadelphia, PA 19141
Phone: (215) 456-7200
Fax: (215) 456-7165

Copyright 2013 Office of Development Einstein Healthcare Network  Privacy Policy


Home
| Donate | Events | Contact Us

Copyright 2013 Office of Development Einstein Healthcare Network  Privacy Policy